Algry Quimica Increases Sales 35%

Madrid (Spain) - Algry Quimica, the world leading company in choline derivatives manufacturing for nutraceutical uses, announced today that the sales of cholines derivatives increased 35% during the first semester, over June 2001 results.This increase is mainly due to its US expandion policy and the increasing exports of its products to nutritional and nutraceutical companies worldwide, specifically to Europe and North and South America, thanks to a wide representatives network which enables Algry Quimica to be active in more than 25 countries today.

For more information:
ALGRY Quimica
Mateo Inurria 30, E-28036 Madrid SPAIN
[email protected]
Tel.: +34.91.343.33.26
Fax.: +34.91.345.29.47 -

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.